Diaz, R. S., Fackler, O. T., & Lusic, M. (2019). Potential impact of the antirheumatic agent auranofin on proviral HIV-1 DNA in individuals under intensified antiretroviral therapy: Results from a randomised clinical trial. International journal of antimicrobial agents, 54(5), . https://doi.org/10.1016/j.ijantimicag.2019.08.001
Chicago-Zitierstil (17. Ausg.)Diaz, Ricardo Sobhie, Oliver Till Fackler, und Marina Lusic. "Potential Impact of the Antirheumatic Agent Auranofin on Proviral HIV-1 DNA in Individuals Under Intensified Antiretroviral Therapy: Results from a Randomised Clinical Trial." International Journal of Antimicrobial Agents 54, no. 5 (2019). https://doi.org/10.1016/j.ijantimicag.2019.08.001.
MLA-Zitierstil (9. Ausg.)Diaz, Ricardo Sobhie, et al. "Potential Impact of the Antirheumatic Agent Auranofin on Proviral HIV-1 DNA in Individuals Under Intensified Antiretroviral Therapy: Results from a Randomised Clinical Trial." International Journal of Antimicrobial Agents, vol. 54, no. 5, 2019, https://doi.org/10.1016/j.ijantimicag.2019.08.001.